CCL21

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT01433172 Comparator	Mar 2012 → Jan 2016	adenocarcinoma, lung cancer	H. Lee Moffitt Cancer Center and Research Institute	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	CCL21	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01433172 ↗
Modality	Protein / enzyme biologic	“CCL21 is a chemokine (protein) that helps to recruit T cells” NCT01433172 ↗